Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Technology:
AgeTech Companies
Funding Status:
N/A
Number Of Exists:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Employee Number:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Industry:
UK AgeTech 2020